Predicting distant failure in nasopharyngeal cancer

Laryngoscope

Volumn 106, Issue 6, 1996, Pages 765-771

  Koukourakis, Michael I ^a   Whitehouse, Routh M ^b   Giatromanolaki, Alexandra ^c   Saunders, Mark ^b   Kaklamanis, Loukas ^c  

^a UNIVERSITY HOSPITAL OF IRAKLION   (Greece)

^b CHURCHILL HOSPITAL   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TREATMENT FAILURE;

EID: 0029994706     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-199606000-00019     Document Type: Article

References (27)

1. Marks JE, Bedwinek JM, Lee F, et al. Dose-response analysis for nasopharyngeal carcinoma. An historical perspective. Cancer. 1982;50:1042-1050.
2. Huang SC, Lui LT, Lynn TC. Nasopharyngeal cancer: study III. A review of 1206 patients treated with combined modalities. Int J Radiat Oncol Biol Phys. 1985;11:1789-1793.
3. Teo PML, Tsao SY, Ho JHC, et al. A proposed modification of the Ho stage-classification for nasopharyngeal carcinoma. Radiother Oncol. 1991;21:11-23.
4. Teo PML, Leung SF, Choi P, et al. Afterloading radiotherapy for local persistence of nasopharyngeal carcinoma. Br J Radiol. 1994;67:181-185.
5. Tannock I. Combined modality treatment with radiotherapy and chemotherapy. Radiother Oncol. 1989;16:83-101.
6. Shanmugaratnam K, Sobin LH. Histological typing of upper respiratory tract tumours. In: International Histological Classification of Tumours. No. 19. Geneva, Switzerland: World Health Organization; 1978.
7. American Joint Committee on Cancer. Manual for Staging of Cancer. 3rd ed. Chicago: The American Joint Committee; 1988.
8. Neel HB III. Nasopharyngeal carcinoma. Clinical presentation, diagnosis, treatment and prognosis. Otolaryngol Clin North Am. 1985;8:479-490.
9. Ho JHC. Stage classification of nasopharyngeal carcinoma. In: Nasopharyngeal Carcinoma: Etiology and Control. de The G, Ito Y, eds. 99-113. Lyon, France:IARC Scientific Publications; No. 20, 1978.
10. Li CC, Pan QC, Chen JJ. Clinical and experimental research on carcinoma of the nasopharynx in science technology. Guangdong Prov. 1983;192-252.
11. Bonnadona G, Robustelli C. Manuale di Oncologia Medica. 2nd ed., Mason, eds. 1985:403.
12. Bonadona G, Valagusa P, et al. Ten year experience with CMF-based adjuvant chemotherapy in resectable breast cancer. Breast Cancer Res Treat. 1985;5:95-115.
13. Dillman RO, Seagren SL, Propert K, et al. A randomized trial of induction chemotherapy plus high dose radiation versus radiation alone in stage III non small cell lung cancer. N Engl J Med. 1990;323:940-945.
14. Mattson K, Holsti LR, Holsti P, et al. Inoperable non small cell lung cancer: radiation with or without chemotherapy. Eur J Cancer Clin Oncol. 1988;24:477-482.
15. Caraguti A, Pradier R, Dela Torre A. Combination chemotherapy (CT) preradical treatment for head and neck squamous cell carcinoma. Proc Am Soc Clin Oncol. 1988;7:152.
16. Martin M, Mazeron JJ, Brun B, et al. Neo-adjuvant polychemotherapy of head and neck cancer: results of a randomized study. Proc Am Soc Clin Oncol. 1988;7:152.
17. Fountzilas G, Daniilidis J, Sridhar KS, et al. Induction chemotherapy with a new regimen alternating cisplatin, fluorouracil with mitomycin, hydroxyurea and bleomycin in carcinomas of nasopharynx and other sites of the head and neck region. Cancer. 1990;66:1453-1460.
18. Fletcher GH. The place of irradiation in the management of metastatic neck disease. Front Radiat Ther Oncol. 1988;22: 111-120.
19. Dimery IW, Peters LJ, Goepfert H, et al. Effectiveness of combined induction chemotherapy and radiotherapy in advanced nasopharyngeal carcinoma. J Clin Oncol. 1993;11: 1919-1928.
20. Rossi A, Molinari R, Boracchi P, et al. Adjuvant chemotherapy with vincristine, cyclophosphamide and doxorubicin after radiotherapy in locoregional nasopharyngeal cancer: results of a 4 year multicenter randomized study. J Clin Oncol. 1988;6:1401-1410.
21. En-Pee Z, Pei-gun L, Kuang-Long C, et al. Radiation therapy of nasopharyngeal carcinoma: prognostic factors based on a 10-year follow-up of 1302 patients. Int J Radiat Oncol Biol Phys. 1989;16:301-305.
22. Zini G, Alberti G, Armatoli L, et al. Analysis of prognostic factors in 106 cases of carcinoma of the rhinopharynx treated with cobalt therapy. Radial Med (Torino). 1989;78:430-434.
23. Chen KY, Fletcher GH. Malignant tumors of the nasopharynx. Radiology. 1971;99:165-171.
24. Mesic JB, Fletcher GH, Goepfert H. Megavoltage irradiation of epithelial tumors of the nasopharynx. Int J Radiat Oncol Biol Phys. 1981;7:447-453.
25. Hoppe RT, Goffinet DR, Bagshaw MA. Carcinoma of the nasopharynx. Eighteen years' experience with megavoltage radiation therapy. Cancer. 1976;37:2605-2612.
26. Neel HB III, Taylor WF, Pearson GR. Prognostic determinants and a new view of staging for patients with nasopharyngeal carcinoma. Ann Otol Rhinol Laryngol. 1985;94:529-537.
27. Bedwinek JM, Perez CA, Keys DJ. Analysis of failures after definitive irradiation for epidermoid carcinoma of the nasopharynx. Cancer. 1980;45:2725-2729.